4D Molecular Therapeutics, Inc. (FDMT)
13.17
-0.32
(-2.37%)
USD |
NASDAQ |
Sep 11, 16:00
13.15
-0.02
(-0.15%)
After-Hours: 20:00
4D Molecular Therapeutics Price : 13.17 for Sept. 11, 2026
Price Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Sep 11, 2026 | 13.69 | 14.02 | 12.94 | 13.17 | 481190.0 |
| Sep 10, 2026 | 13.88 | 14.02 | 13.40 | 13.49 | 566243.0 |
| Sep 09, 2026 | 14.44 | 14.50 | 14.08 | 14.18 | 493798.0 |
| Sep 08, 2026 | 14.57 | 15.29 | 14.13 | 14.63 | 542040.0 |
| Sep 04, 2026 | 14.50 | 15.00 | 14.33 | 14.97 | 420636.0 |
| Sep 03, 2026 | 14.94 | 14.94 | 14.28 | 14.70 | 782447.0 |
| Sep 02, 2026 | 14.40 | 15.13 | 14.08 | 14.94 | 1.036M |
| Sep 01, 2026 | 13.94 | 14.85 | 13.80 | 14.35 | 707964.0 |
| Aug 31, 2026 | 14.49 | 14.60 | 13.66 | 14.11 | 1.404M |
| Aug 28, 2026 | 14.92 | 15.00 | 14.20 | 14.67 | 1.101M |
| Aug 27, 2026 | 15.44 | 15.77 | 14.82 | 14.91 | 717739.0 |
| Aug 26, 2026 | 15.50 | 15.67 | 15.04 | 15.56 | 717885.0 |
| Aug 25, 2026 | 15.69 | 16.34 | 15.42 | 15.72 | 919118.0 |
| Aug 24, 2026 | 15.68 | 15.83 | 14.35 | 15.39 | 1.475M |
| Aug 21, 2026 | 16.32 | 16.91 | 15.33 | 15.83 | 921169.0 |
| Aug 20, 2026 | 16.50 | 16.71 | 15.63 | 16.10 | 1.631M |
| Aug 19, 2026 | 15.21 | 16.93 | 14.89 | 16.76 | 1.965M |
| Aug 18, 2026 | 14.25 | 15.04 | 13.91 | 14.72 | 2.320M |
| Aug 17, 2026 | 12.20 | 15.02 | 12.10 | 14.54 | 3.453M |
| Aug 14, 2026 | 11.63 | 12.35 | 11.26 | 12.19 | 773765.0 |
| Aug 13, 2026 | 11.93 | 12.05 | 11.34 | 11.65 | 707434.0 |
| Aug 12, 2026 | 11.50 | 11.89 | 11.34 | 11.87 | 430296.0 |
| Aug 11, 2026 | 11.31 | 11.54 | 10.80 | 11.47 | 453665.0 |
| Aug 10, 2026 | 10.66 | 11.30 | 10.54 | 11.14 | 940939.0 |
| Aug 07, 2026 | 10.66 | 10.84 | 10.45 | 10.75 | 346898.0 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Amgen, Inc. | 377.35 |
| AnaptysBio, Inc. | 53.87 |
| Precision BioSciences, Inc. | 7.17 |
| Design Therapeutics, Inc. | 14.63 |
| Inhibrx Biosciences, Inc. | 109.27 |
Price Related Metrics
| PS Ratio | 9.020 |
| Price to Book Value | 1.784 |
| Earnings Yield | -20.69% |
| Market Cap | 727.17M |